SOPHIA GENETICS SA (SOPH)
CH1125843347 - Common Stock
SOPHIA GENETICS SA
NASDAQ:SOPH (9/16/2024, 8:00:02 PM)
3.99
-0.02 (-0.5%)
Company Profile
SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. The company is headquartered in Rolle, Vaud and currently employs 449 full-time employees. The company went IPO on 2021-07-23. The firm offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The firm has offices in Switzerland, France and the United Kingdom and operates worldwide.
Company Info
SOPHIA GENETICS SA
La Piece 12
Rolle VAUD
P: 41216941060
CEO: Jurgi Camblong
Employees: 449
Website: https://www.sophiagenetics.com/
SOPH News
3 days ago - Sophia GeneticsSOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024/PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, will unveil new research at...
5 days ago - Sophia GeneticsSOPHiA GENETICS Announces Poster Presentations at ESMO 2024/PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, will be presenting...
5 days ago - SOPHiA GENETICSSOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an update...
5 days ago - Sophia GeneticsSOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024/PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an...
7 days ago - SOPHiA GENETICSSOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced a new...
7 days ago - Sophia GeneticsSOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing/PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced a new...
SOPH Twits
Here you can normally see the latest stock twits on SOPH, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
